Posts Tagged: "GE Healthcare"

General Electric beats recent earnings estimates, focuses on healthcare and energy R&D

Medical and healthcare technologies were again prevalent when taking a survey of GE patent applications recently published by the USPTO. Techniques for determining a better course of treatment when dealing with cancer are described within U.S. Patent Application No. 20150198599, filed under the title TLE3 as a Marker for Chemotherapy. The patent application would protect a method of identifying a breast cancer that will not respond favorably to a chemotherapy treatment that includes either taxane or a taxane derivative; the method involves performing immunohistochemical staining for TLE3 polypeptide on a cancer sample. This technology enables a more effective process of selecting chemotherapies to administer to a patient, especially when the therapy in question is paclitaxel, which carries adverse side effects.

Steve Brachmann

August 10, 2015

GE Patents: Patents of Note: Medical Inventions & Alternative Energy Systems

General Electric has been awash in recently issued patents pertaining to medical technologies, and we discuss an intriguing collection of these inventions. One patent protects an improved anaesthesia delivery system that monitors oxygen levels in patients undergoing anaesthesia. Another protects a system for recognizing family relationships among patients for better tracking of medical histories. Finally, we look at a couple of patents protecting technologies for energy generation systems, including one protecting a method of monitoring communication networks in wind farms to quickly identify network issues which need to be fixed for accurate energy production reporting.

Steve Brachmann

August 1, 2014

Patent Deals, Licenses and Settlements – December 2012

Without doubt, the biggest patent deal of the month related to Kodak’s sale of its non-core patent portfolio to Intellectual Ventures, RPX and others for $525 million. But there were other interesting patent business deals, including: (1) Microsoft and EINS Sign Android Patent Agreement; (2) NIH Awards Contract for Improved Anthrax Vaccine; (3) ARRIS To Acquire Motorola Home Business For $2.35 Billion; (4) Mylan Announces Comtan® Settlement Agreement; (5) Trovagene Licenses Duke University, Novartis; (6) Amgen Finalizes Agreement Resolving Federal Investigations; (7) GE Healthcare, CDI Agree to Sublicense for Cellular Assay Patents; and more.

Gene Quinn & Angel Krippner

December 30, 2012